RxDoctor Payments Data

Jack Lee, MD

MOHS-Micrographic Surgery · Newtown, PANPI 1538653217

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $820 of the $920 with a category attached, or 89.1%. 16 manufacturers reported payments, led by Johnson & Johnson at 30.1% of the total. 2025 is the largest year on record at $423, 2.3 times the $185 reported in 2023. That places this record below the midpoint for mohs-micrographic surgery clinicians in PA, where the typical reported total is $1,161.

$920in general payments, 2019–2025

Across 38 payments — averaging $24.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$277
  • Sanofi-aventis U.S. LLC$100
  • Arcutis Biotherapeutics, Inc.$87
  • Novartis$68
  • Sun Pharmaceutical Industries Inc.$67
  • UCB, Inc.$60
  • plus $260 from 10 others

What the payments were for

  • Food & beverage$82089%
  • Education$10011%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$920 in reported general payments places this provider in the 35th percentile of 48 mohs-micrographic surgery providers in Pennsylvania.

See all mohs-micrographic surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$277,350
Medicare patients
281
Services billed
1,437

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gentamicin Sulfate43$1,521
Fluorouracil18$1,127
Clobetasol Propionate29$649
Ketoconazole26$512
Mupirocin59$416
Triamcinolone Acetonide31$367
Cefadroxil55$348
Selenium Sulfide25$274
Doxycycline Hyclate11$117

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Newtown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →